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Abstract 
Compared with the extensor longus digitorum (EDL) muscle of control rats (C), 
the EDL muscle of rats fed a low-protein, high-carbohydrate (LPHC) diet 
showed a 36% reduction in mass. Muscle mass is determined by the balance 
between protein synthesis and proteolysis; thus, the aim of this work was to 
evaluate the components involved in these processes. Compared with the 
muscle from C rats, the EDL muscle from LPHC diet-fed rats showed a 
reduction (34%) in the in vitro basal protein synthesis and a 22% reduction in 
the in vitro basal proteolysis suggesting that the reduction in the mass can be 
associated with a change in the rate of the two processes. Soon after 
euthanasia, in the EDL muscles of the rats fed the LPHC or C diet for 15 days, 
the activity of caspase-3 and of components of the ubiquitin-proteasome system 
(atrogin-1 content and chymotrypsin-like activity) were decreased. The 
phosphorylation of p70S6K and 4E-BP1, proteins involved in protein synthesis, 
was also decreased. We observed an increase in the insulin-stimulated protein 
content of p-Akt. Thus, the higher insulin sensitivity in the EDL muscle of LPHC 
rats seemed to contribute to the lower proteolysis in LPHC rats. However, even 
with the higher insulin sensitivity, the reduction in p-E4-BP1 and p70S6K 
indicates a reduction in protein synthesis, showing that factors other than insulin 
can have a greater effect on the control of protein synthesis.  
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1. Introduction 
In developing countries, malnutrition is an early and usual event in the human 
life. Normally, children in these countries consume a great amount of 
carbohydrates and a small quantity of protein, which can lead to structural 
damage in several organs and increased mortality [1, 2]. 
Skeletal muscle is considered the most abundant tissue in the body, making up 
approximately 40-50% of the total body mass and serving as the largest body 
protein pool [3, 4]. Skeletal muscle exhibits a high resting metabolic rate and is 
one of the most adaptable tissues that responds to numerous external and 
physiological stimuli [5], which induce changes in its phenotypic profile in terms 
of size and composition [6]. Thus, particularly in conditions of protein 
malnutrition, the adaptations of muscles are fundamental to body homeostasis. 
Several authors have suggested that protein restriction during the critical stage 
of development results in a reduction in the skeletal muscle mass and in the 
number and size of fibers [7, 8], along with higher vulnerability to atrophic 
reactions [9]. However, other authors have shown that muscle fibers are 
capable of adapting their metabolism, optimizing protein turnover to preserve 
the primary functions in malnutrition conditions [10-13].  
Studies from our research group showed that rats that were fed a low-protein, 
high-carbohydrate diet (LPHC; 6% protein and 74% carbohydrate) for 15 days 
soon after weaning showed an increase in the diet and calorie intake with a 
reduction in the body weight gain compared to the corresponding factors in the 
rats fed a control diet (C; 17% carbohydrate and 63% protein) [14]. Even when 
the increase in the food intake was accounted for, the LPHC rats ingested 60% 
less protein than the rats fed the C diet at the end of 15 days, which was 
confirmed by the reduced post-prandial amino acid concentration in the blood of 
these rats [14]. The protein-deficient state in LPHC rats could also be indicated 
by the hypoproteinemia and impairment in the body growth (evaluated by Lee 
index) compared to the condition of the rats receiving a C diet [13]. Moreover, 
LPHC rats showed a reduction in the body mass with a higher energetic gain as 
a consequence of an increase in the body lipid content and a reduction in the 
water and protein contents [13] (data are shown in Table S1 of the 
supplementary material). Additionally, the LPHC diet promotes an increase in 
serum epinephrine and norepinephrine levels, and 10 times higher levels of 
tumor necrosis factor alpha (TNF-α) and 100% higher levels of corticosterone 
and leptin [13, 15, 16]; thus, the LPHC diet seems to promote a highly catabolic 
environment (data are shown in Table S2 of the supplementary material). A 
previous study also showed a reduction in the mass of different skeletal 
muscles in LPHC rats compared with C rats [13]. 
The mass and protein content of skeletal muscle are determined by the 
dynamic equilibrium between the rates of protein synthesis and proteolysis [6]. 
In addition to the availability of essential amino acids, insulin and insulin-like 
growth factor-1 (IGF-1) are considered to be factors that mediate normal muscle 
development [17, 18]. These factors bind with their respective receptors, 
resulting in activation/phosphorylation of protein kinase B (PKB), also known as 
Akt. Akt stimulates protein synthesis by activating the mammalian target of 
rapamycin (mTOR) and its downstream effectors and inhibits glycogen 
synthase kinase-3β, a negative regulator of protein synthesis [19]. Activation of 
Akt also induces the phosphorylation of the forkhead box transcription factor 
(Foxo) and its subsequent nuclear exclusion, which results in the inhibition of 
atrogene transcription and consequently in the inhibition of proteolysis [20]. 
In turn, there are different proteolytic systems in cells. Intracellular proteolysis 
may occur in lysosomes after fusion with the autophagosome, which requires 
the expression of microtubule-associated protein 1 light chain 3 beta (LC3) and 
gamma-aminobutyric acid receptor-associated protein (GABARAP). The 
proteolytic capacity of the lysosomes is determined by the activity of cathepsins 
L, B, D and H [21]. Extralysosomal proteolytic pathways in the skeletal muscle 
cells of mammals include the calpains or Ca2+-dependent proteases, caspase-3 
and the ubiquitin-proteasome proteolytic system [16]. The specificity in protein 
breakdown by this last proteolytic system is dependent on the content of 
ubiquitin ligase enzymes (E3s). Two E3s, muscle F-box protein atrogin-1 
(atrogin-1 or MAFbx) and the protein muscle RING finger-1 (MuRF-1) are 
known as atrogenes, and they play a decisive role in mediating the loss of 
muscle mass [20]. Studies indicate the participation of calpains and caspase-3 
in the dissociation of actin and myosin from myofibrils before they are degraded 
by the proteasome [22, 23]. 
A previous study on soleus muscles of LPHC rats showed that the reductions in 
mass and protein content resulted from decreases in protein synthesis [14] and 
overall proteolysis. The proteolysis was reduced mainly due to inhibition of both 
the ubiquitin-proteasome system and caspase-3 activity [14]. The results also 
indicated higher insulin sensitivity in the soleus muscles of the LPHC rats, which 
was evidenced by increases in the insulin receptor content and in insulin-
stimulated Akt phosphorylation [14], suggesting that the higher insulin sensitivity 
in the soleus muscle of the LPHC rats was responsible for the inhibition of the 
proteolytic processes.  
However, the alterations observed in the protein metabolism of the soleus 
muscles from LPHC rats are not necessarily valid for other skeletal muscles 
because the metabolic response in different metabolic situations seems to be 
muscle-type specific. Differences in the sensitivity of skeletal muscles to dietary 
manipulations have also been reported by several authors. Mizushima et al. [24] 
showed that transgenic mice subjected to nutrient starvation experienced rapid 
and intense macroautophagy in the extensor digitorum longus (EDL) muscle, 
which almost exclusively contains fast-twitch fibers (glycolytic, type II), and 
experienced moderate and slow macroautophagy in the soleus muscles, which 
contains a high percentage of slow-twitch fibers (oxidative, type I). Furthermore, 
the regulation of extralysosomal proteolytic pathways can differ in skeletal 
muscles with different fiber-type compositions [25, 26].  
Thus, the aim of this study was to evaluate the effect of the LPHC diet on 
components of the systems for protein synthesis and proteolysis as the first 
stage in establishing possible mechanisms that explain the reduced mass of 
EDL muscle. For this purpose, we evaluated the following in EDL muscles from 
control and LPHC rats: 1. mass and protein content of the EDL muscle; 2. in 
vitro basal protein synthesis and proteolysis; 3. protein contents and enzyme 
activities related to proteolytic pathways; 4. insulin signaling pathway protein 
content; 5. basal and phosphorylated contents of 4E-BP1, p70S6K, GSK-3β, 
CREB and AMPK, which are proteins involved in the regulation of protein 
synthesis; and 6. basal and phosphorylated content of Foxo1, which is involved 
in the regulation of proteolysis. 
2. Methods and Materials. 
 
2.1. Animals and treatment. 
The animals used in the experiments were provided by the Central Animal 
House of Universidade Federal de Mato Grosso (UFMT). The animals were 
handled according to the Brazilian College of Animal Experimentation 
Regulations, and the experiments were approved by the Animal Ethics 
Committee of UFMT (protocol no. 23108.043335/08-1). Male Wistar rats (5-10 
animals) with an initial body weight of approximately 90-100 g (~30 days old) 
were randomly distributed into 2 groups: i) control group (C) that was fed a diet 
composed of 17% protein, 63% carbohydrate and 7% lipid and ii) LPHC group 
that was fed a diet composed of 6% protein, 74% carbohydrate and 7% lipid. 
The reduction of protein in the LPHC diet, in term of calories, was compensated 
by carbohydrates (Table 1). The diets are isocaloric (16.3 kJ·g–1) and were 
administered for 15 days. The rats were housed in individual metabolic cages at 
22 ± 1 °C with a 12 h:12 h light:dark cycle; they also received water and food ad 
libitum. The body weight and food intake of each rat were recorded daily. All 
rats were euthanized on the 15th day of treatment, and the EDL muscles were 
collected, weighed and stored at -80 ºC or immediately used in experiments.  
 
2.2 Total protein content of the EDL skeletal muscle 
For the LPHC and C fed rats, both EDL muscles (right and left) were used for 
the analysis. The muscles were minced and homogenized using a glass-Teflon 
homogenizer (Wheaton Overhead Stirrer) in buffer containing 50 mM potassium 
phosphate dibasic, 5 mM EDTA, 0.5 mM DTT, 1.15% KCl, 1 mM phenylmethyl 
sulfonyl fluoride, 5 µg·mL-1 aprotinin and 1 µg·mL-1 leupeptin at pH 7.4 in a 
proportion of 4% wt/vol. The homogenate was centrifuged at 600 g for 10 min at 
4ºC. The total protein content was determined by the Bradford method [27], and 
the data are expressed in mg·g-1 muscle. 
 
2.3. In vitro, basal protein synthesis and proteolysis. 
Groups of rats were treated with the C or LPHC diets. After 15 days of 
treatment, the animals in the fed state were euthanized, and the muscles were 
removed and incubated for the in vitro evaluation of the protein synthesis. The 
same process was performed with another set of rats from the C and LPHC 
groups for the evaluation of muscle proteolysis.     
The EDL muscles were rapidly dissected, weighed and fixed by the tendon in 
appropriate supports (to maintain the muscles at the resting length) and 
incubated in Erlenmeyer flasks (1 muscle/flask) containing Krebs-Ringer 
bicarbonate buffer (0.120 M NaCl, 0.015 M NaHCO3, 4.828 mM KCl, 1.2 mM 
MgSO4, 1.212 mM KH2PO4, 2.4 mM CaCl2 at pH 7.4) and 5 mM glucose, and 
aerated with 95% O2 and 5% CO2. 
The in vitro basal protein synthesis was evaluated as previously described [14, 
28]. After a 1-h pre-incubation period at 37°C with shaking, the EDL muscles 
were incubated in the same Krebs-Ringer bicarbonate buffer described above 
containing all amino acids at concentrations similar to those of the rat plasma 
during fed period [29] and L-[U-14C] tyrosine (0.05 µCi/mL) for 2 h. After the 
incubation, the specific activity of the intracellular tyrosine pool in each muscle 
was estimated by measuring the radioactivity and the concentration of free 
tyrosine. After measurement of the radioactivity incorporated into the protein of 
the same muscle, the in vitro basal protein synthesis was calculated using the 
specific activity of the intracellular pool of tyrosine, assuming that there was no 
recycling of the label during the incubation period [14]. 
The in vitro basal proteolysis was evaluated as previously described [14, 30], by 
determination of the tyrosine release in the medium. After a 1-h pre-incubation 
period at 37°C with shaking, the EDL muscles were incubated for 2 h in the 
same Krebs-Ringer bicarbonate buffer described above without any amino 
acids in the medium but with 0.5 mM cycloheximide to prevent protein synthesis 
and the reincorporation of the released tyrosine back into proteins. At the end of 
the incubation period, 1 mL of the medium was collected and added to 0.25 mL 
of perchloric acid (1.5 N), and the released tyrosine was evaluated using the 
fluorimetric method described by Waalkes and Udenfriend [31]. 
 
2.4. Enzyme activities. 
The activities of caspase-3, calpain, cathepsin B and proteasome 
(chymotrypsin-like activity) were determined ﬂuorometrically (PerkinElmer) with 
excitation and emission wavelengths of 380 and 460 nm, respectively. The 
protein content of the muscle homogenates was determined by the Bradford 
method [27]. The enzyme proteolytic activities were determined by 
measurement of the released ﬂuorogenic product (AMC; 7-amino-4-
methylcoumarin), and a standard curve of AMC was prepared (Calbiochem). 
Data are expressed in nmol of AMC·mg protein-1·min-1. 
Chymotrypsin-like proteasome activity was assayed according to Klaude et al. 
[32]. EDL muscles were homogenized in Tris-HCl buffer (pH 7.2) containing 50 
mM Tris-HCl, 1 mM EDTA, 100 mM KCl, 5 mM MgCl2, and 1.8 mM ATP. The 
homogenate was centrifuged at 700 g at 4 °C for 10 min to remove cell debris. 
The supernatant was centrifuged at 15,000 g for 10 min. Glycerol was then 
added to the supernatant (10% v/v), which was used to measure the total 
protease activity. Duplicates of the supernatant were incubated with the assay 
buffer (50 mM Tris-HCl, 1 mM ATP, 5 mM MgCl2, and 1 mM DTT; pH 7.5), and 
150 µM substrate succinyl-Leu-Leu-Val-Tyr-AMC (Calbiochem, Germany) was 
added after 1 min of stabilization. In parallel, the same incubation procedure 
was performed with the addition of proteasome inhibitor (100 µM MG132; 
Sigma Aldrich) to the mixture. After incubation at 37°C for 45 min, the reaction 
was stopped by the addition of 100 mM sodium acetate buffer (pH 4.3). The 
proteasome activity was determined by the difference between the amounts of 
AMC generated in the absence and the presence of MG 132. 
Calpain activity was assayed according to Douillard et al. [33]. EDL muscles 
were homogenized in Tris-HCl buffer (pH 7.4) containing 20 mM Tris–HCl, 5 
mM EDTA, 0.1% Triton X-100 and 1 mM DTT. The homogenates were 
centrifuged at 1,000 g at 4 °C for 10 min to remove cell debris. The calpain 
activity was measured using the same substrate mentioned above. Duplicates 
of the supernatant were incubated with the assay buffer (20 mM Tris-HCl, 5 mM 
CaCl2 and 1 mM DTT; pH 7.4), and after 5 minutes, the substrate was added 
(50 µM).  In parallel, the same incubation procedure (at 37°C for 30 min) was 
performed with the addition of calpain inhibitor (50 µM calpeptin; Santa Cruz 
Biotechnology) to the mixture (20 mM Tris-HCl, 10 mM EDTA and 1 mM DTT; 
pH 7.4). The reaction was stopped by the addition of the stop buffer (100 mM 
sodium chloroacetate, 30 mM sodium acetate and 70 mM acetic acid; pH 4.3). 
The calpain activity was determined by the difference between the amounts of 
AMC generated in the absence and presence of calpeptin. 
Caspase-3 activity was determined as described by Du et al. [34], with minor 
modiﬁcations. Briefly, EDL muscles were homogenized in HEPES buffer (100 
mM HEPES, 10% sucrose, 0.1% Triton X-100, and 10 mM DTT; pH 7.5) and 
centrifuged at 15,000 g for 45 min. The supernatant was added to the assay 
buffer (100 mM HEPES, 10 mM DTT, 10% sucrose; pH 7.5), and the mixture 
was pre-incubated at 30°C for 30 min. The substrate for caspase-3, Ac-Asp-
Glu-Val-Asp-AMC (Calbiochem, Germany), was added (50 µM), and the mixture 
was incubated at 30°C for 60 min. The reaction was stopped by the addition of 
100 mM sodium acetate buffer (pH 4.3). The caspase-3 activity was determined 
considering data from the standard curve of AMC. 
Cathepsin-B activity was determined as described by Barrett and Kirschke [35].  
Briefly, EDL muscles were homogenized in 20 mM sodium phosphate buffer 
(pH 6.0) containing 0.15 M KCl and 0.1% Triton X-100 and centrifuged at 
15,000 g at 4°C for 10 min. Duplicates of the supernatant were pre-incubated 
with assay buffer (340 mM sodium acetate, 60 mM acetic acid, 4 mM disodium 
EDTA, and 8 mM DTT; pH 5.5) at 30°C.  After one minute, 20 µM of the 
substrate for cathepsin B (Z-Arg-Arg-AMC, 2 HCl; Calbiochem) was added. The 
reaction was stopped after 20 min by the addition of the same stop buffer used 
in the calpain activity evaluation. The cathepsin-B activity was determined 
considering data from the standard curve of AMC. 
 
2.5. Insulin signaling study. 
Rats from the C or LPHC groups were fasted for 5 h and were then 
intraperitoneally injected with saline (C and LPHC non-stimulated groups) or 
insulin (10 mU/g body weight; C and LPHC stimulated groups).  Ten minutes 
after the insulin or saline administration, the animals were anaesthetized with a 
mixture of ketamine hydrochloride (Dopalen, Agribrands) and xylazine 
hydrochloride (Rompun, Bayer®) (2:1), and after the loss of pedal and corneal 
reflexes, the EDL muscles were quickly removed. The protein content of the 
insulin receptor (IRβ) and Akt and the p-AKt protein content were determined 
through Western blotting. 
 
2.6. Western blot for protein analysis 
EDL muscles from C and LPHC rats were homogenized in 50 mM Tris-HCl 
buffer pH 7.4, at 4°C, containing 1% Triton X-100, 150 mM sodium chloride, 10 
mM sodium pyrophosphate, 100 mM sodium fluoride, 1 mM 
ethylenediaminetetraacetic acid, 10 mM sodium orthovanadate, 1 mM 
phenylmethyl sulfonyl fluoride, and 5 µg·mL-1 aprotinin. The total protein 
concentration was determined by the Bradford method [27]. For each sample, 
100 µL of total homogenate was incubated for 5 min at 100ºC with Laemmli 
buffer (0.250 mM Tris-HCl buffer at pH 6.8, 0.5% bromophenol blue, 50% 
glycerol, 10% sodium dodecyl sulfate, and 500 mM dithiothreitol) (4:1, v/v). 
Samples containing 100 µg of protein were separated by 8% to 10% SDS-
PAGE, transferred to nitrocellulose membranes and blotted with the following 
antibodies: anti-cathepsin L (1:500; Santa Cruz), anti-cathepsin B (1:500; Santa 
Cruz), anti-ubiquitin conjugates (1:1000; Santa Cruz), anti-LC3 (1:1000; Santa 
Cruz), anti-GABARAP (1:1000; Santa Cruz), anti-AMPK (1:1000; Cell 
Signaling), anti-phospho-[Thr-172]-AMPK (1:1000; Cell Signaling), anti-IRβ 
(1:750; Santa Cruz), anti-Akt (1:500; Santa Cruz), anti-phospho-[Ser-473]-
Akt1/2/3 (1:500; Santa Cruz), anti-CREB (1:750; Cell Signaling), anti-phospho-
[Ser-33]-CREB (1:750; Cell Signaling), anti-Foxo1 (1:500; Cell Signaling) and 
anti-phospho-[Thr-24]-Foxo1 (1:500; Cell Signaling), anti-atrogin-1 (1:1000; c), 
anti-4E-BP1 (1:500; Cell Signaling), anti-phospho-[Thr-70]-4E-BP1 (1:500; Cell 
Signaling), anti-p70S6K (1:500; Cell Signaling), anti-phospho-[Thr70]-p70S6K 
(1:500; Cell Signaling), anti-GSK-3β (1:500; Cell Signaling), anti-phospho-[Ser-
21/9]-GSK-3 (1:500; Cell Signaling) and anti-α-tubulin (1:750; Santa Cruz). All 
antibodies used are recommended for the detection of rat proteins. Proteins 
were detected after membrane incubation overnight (4ºC) in the respective 
primary antibodies diluted in TBS-T containing 5% dry albumin. Specific bands 
were detected with a Supersignal West Pico chemiluminescent substrate 
(Pierce), and the protein band intensity was normalized to the α-tubulin band 
intensity (internal control). The band intensity was quantified with the ImageJ 
Program (Wayne Rasband, National Institutes of Health, New York, NY), and 
the results are expressed as the relative ratio using the internal control as the 
baseline.  
 
2.7. Statistical analysis 
All data were expressed as the mean ± standard error (SE) for the number of 
rats indicated between parentheses. Statistical analysis was performed using 
the Statistica Software package (Statsoft, Tulsa, OK, USA). Bartlett’s test for the 
homogeneity of variances was initially used to determine whether the data 
complied with the assumptions for parametric analysis of variance. When 
necessary, the data were log-transformed to correct for variance in 
heterogeneity or non-normality. All statistical significances of the other 
experiments were analyzed using Student´s t-test. The sample size used in all 
experiments was calculated by considering a 15% coefficient of variation for the 
biological effect [36]. A value of p<0.05 was taken as the criterion for 
significance. 
 
3. Results 
3.1 General physiological and biochemical parameters. 
At the end of the 15th day of treatment, the total food intake of the LPHC rats 
was approximately 13% higher than that of the control rats. However, despite 
this increase in the food intake, the total protein intake and final body weight of 
the LPHC rats were 61% and 23% lower, respectively, than the control rats. 
These data are in agreement with previously published results by our laboratory 
[13-16]. 
The reduction in body weight of the LPHC rats was accompanied by a reduction 
in the mass (36%) and protein content (34%) of the EDL muscles (Table 2) 
compared with the values of the control rats. 
 
3.2. In vitro, basal protein synthesis and proteolysis.  
The in vitro protein synthesis was markedly lower (34%) in the EDL muscles of 
the LPHC rats than in the control rats (Fig. 1A). Moreover, the LPHC diet 
caused a 22% reduction in the in vitro proteolysis in EDL muscles compared 
with the values found in control rats (Fig. 1B).  
 
3.3. Proteolytic pathways. 
Evaluation of the components of the lysosomal system showed that the EDL 
muscles from the LPHC rats had approximately 52% higher protein content of 
cathepsin B (Fig. 2A), without changes in the cathepsin L content (Fig. 2B). 
Despite the increase in the content of cathepsin B, the activity of this protease 
was similar between the LPHC and C groups (Fig. 2C). Additionally, there were 
no differences in the protein contents of the autophagic components, LC3 and 
GABARAP in the EDL muscles (Fig. 2D) of LPHC rats compared to C rats. 
Proteases related to sarcomere structure proteolysis were also evaluated. The 
LPHC diet had no effect on the calpain activity of EDL muscles (Fig. 3A). 
However, the activity of caspase-3 was 16% lower in the EDL muscles of LPHC 
rats than in the control rats (Fig. 3B). 
Data from the ubiquitin-proteasome system evaluation showed that the atrogin-
1 content was 34% lower in the EDL muscles of the LPHC rats (Fig. 4A). There 
were no differences in the levels of the ubiquitin conjugates of high and low 
molecular weight in the EDL muscles (Fig. 4B). The chymotrypsin-like 
proteasome activity (Fig. 4C) in the EDL muscles was 19% lower in the LPHC 
rats than in the control rats. 
 
3.4. Insulin signaling. 
There were no differences in the protein contents of IRβ and Akt in the EDL 
muscles of the experimental groups. In the control rats, the insulin-stimulated 
Akt phosphorylation was increased by 125% compared with the non-insulin 
stimulated value. In LPHC rats, this increase was approximately 230% relative 
to the basal LPHC (Fig. 5C). 
 3.5 Basal and phosphorylated contents of 4E-BP1, p70S6K, GSK-3β, CREB and 
AMPK (regulation of protein synthesis). 
The evaluation of the contents of protein components involved in the translation 
process showed that the 4E-BP1 content was 50% higher in EDL muscles from 
LPHC rats than in C rats; however, the 4E-BP1 phosphorylation levels were 
42% lower (Fig. 6A). Similarly, there was a significant reduction (70%) in the 
phospho-p70S6K levels in the EDL muscles from LPHC rats, although the LPHC 
diet did not affect the p70S6K content (Fig. 6B). No difference was observed in 
the GSK-3 and p-GSK-3/GSK-3 ratio in the EDL muscles between the LPHC 
and C rats (Fig. 6C). 
We investigated the AMPK and p-AMPK contents because this kinase has an 
important role in the inhibition of protein synthesis by suppression of the 
function of multiple translation regulatory factors. Neither the AMPK protein 
content nor the p-AMPK/AMPK ratio was altered by treatment with the LPHC 
diet for 15 days (Fig. 6D).  
cAMP-response-element binding protein (CREB) is a well-known transcription 
factor target of cAMP-dependent protein kinase (PKA) and is considered the 
major effector of cAMP in skeletal muscles. The CREB levels were similar in the 
EDL muscle of the two groups. However, the LPHC diet reduced the levels of 
phosphorylated CREB by 48% (Fig. 6E). 
 
3.6. Basal and phosphorylated content of Foxo1 (regulation of proteolysis). 
The Foxo1 factor is implicated in the reduction of muscle protein breakdown by 
inhibition of atrogene expression via AKT. The Foxo1 content was not altered 
by the diet, but the Foxo1 phosphorylation was 85% higher in the EDL muscles 
of the LPHC rats than in the C rats (Fig. 7).  
 
4. Discussion 
In vivo and in vitro experiments were performed in the present study with the 
objective of obtaining insight into the protein metabolism in EDL muscles of 
growing rats adapted to the LPHC diet.  Our investigation showed a reduction in 
the mass and protein content of the EDL muscle of LPHC rats compared with C 
rats. Thus, initially, we evaluated the in vitro basal protein synthesis and 
proteolysis in EDL muscles from LPHC and C rats using specific media for each 
evaluations. We observed that the EDL muscle from the LPHC rats showed less 
incorporation of 14C-tyrosine and also less tyrosine release in the medium, 
suggesting lower protein synthesis and proteolysis, respectively.  However, the 
reduction in the 14C-tyrosine incorporation by the muscle was higher than the 
reduction in the tyrosine release by the incubated muscle. These results can 
explain the reduction in the EDL muscle mass. Batistela et al. [14] performed 
the same analyses in the same conditions in the soleus muscle of LPHC rats. 
Comparing our EDL data with the data obtained from the soleus muscle [14], 
we observed that the reduction in the protein synthesis was lower in the soleus 
(~19%) than in the EDL (~34%), whereas the inhibition of the protein 
breakdown was more pronounced in the soleus muscles (~36%) than in the 
EDL (~22%). These results are consistent with the higher mass loss of EDL 
compared with the soleus muscle in LPHC rats: 37% and 27%, respectively. 
The fact that the changes in the activity of these two processes define the mass 
of the muscle is also valid for other muscles and in other situations. Millward et 
al. [12] observed that in the gastrocnemius and quadriceps skeletal muscles of 
rats fed a diet composed of 6.8% protein, the reduced mass observed in those 
muscles resulted from the reduction in the rates of both protein synthesis and 
breakdown.  
Interestingly, EDL muscles of the LPHC rats showed higher insulin sensitivity, 
as evidenced by higher levels of insulin-stimulated AKT phosphorylation. After 
binding to its receptor in the plasma membrane of cells, insulin causes receptor 
autophosphorylation and activation of the signaling cascade, thus activating 
mTOR via Akt. mTOR plays a critical role in the regulation of protein synthesis 
and in the hypertrophy of skeletal muscles [18] because it promotes enhanced 
translation through its downstream targets, the 70 kDa ribosomal protein S6 
kinase (p70S6K) and eukaryotic initiation factor 4E-binding protein 1 (4E-BP1), 
which has a main role in the activation of the initiation stage of the translation 
process in eukaryotic cells. However, our results showed that although the 
insulin signaling is increased, the levels of phosphorylated p70S6K and 
phosphorylated 4E-BP1 in the EDL muscles of LPHC rats were both reduced, 
which explains the lower rate of protein synthesis despite the increase in Akt 
phosphorylation. Thus, it is clear that in addition to insulin, other factors can 
affect or stimulate protein synthesis. In our experimental animal, the amino acid 
availability seems to be a limiting factor.  Nave et al. [37] showed in mammal 
cells that both the mTOR phosphorylation and the protein synthesis that 
occurred in response to insulin were blocked by amino acid deprivation, 
showing that mTOR represents a potential integration point of signals from 
insulin and amino acids. The administration of essential amino acids, mainly 
leucine, also results in an increase in the protein synthesis in skeletal muscle 
through activation of the mTOR pathway [38, 39]. Moreover, in situations when 
the protein synthesis in rat skeletal muscle is lower due to a low level of protein 
in the diet, it is possible to reverse the reduction in the protein synthesis by 
supplementation with leucine [40] or lysine [41]. Previously, we demonstrated 
that in the post-feeding period of LPHC rats, the plasma levels of lysine were 
unaffected, but the leucine levels were reduced by 30% compared with the 
value in control rats [14] (data are shown in Table S3 of the supplementary 
material).  Taken together, these data suggest that the reduced levels of leucine 
may represent an important factor in the reduction of the protein synthesis in the 
EDL muscles of LPHC rats. Additional experiments are necessary to prove this 
possibility.  
For proteolytic pathways, our data showed that the contents of autophagy-
related genes (LC3 and GABARAP) and cathepsin L, as well as the cathepsin B 
activity, remained unchanged in LPHC rats compared with C rats. These data 
suggest that the lysosomal proteolytic system is not involved in the reduction of 
the EDL skeletal muscle of LPHC rats. However, the inhibition of both the 
caspase-3 activity and UPS in the EDL muscle of LPHC rats can reinforce the 
reduced proteolysis observed in the EDL muscle in vitro. The inhibition of the 
UPS was evidenced by the decreases in both the atrogin-1 content and the 
chymotrypsin-like proteasome activity. The expression of atrogenes, including 
atrogin-1, is inhibited by the PI3K/Akt insulin signaling, which is responsible for 
the phosphorylation of the nuclear Foxo transcription factor, which is excluded 
from the nucleus when phosphorylated [42]. Our data showed that the EDL 
muscles from LPHC rats had an increase in the phosphorylation of Foxo1 
accompanied by a reduction in the atrogin-1 content, representing a minor 
decrease in the amount of substrates that are offered to the proteasome. These 
novel results reinforce the data obtained from the in vitro evaluation of 
proteolysis, when we observed lower tyrosine release in the medium, and this 
finding is consistent with the higher insulin-stimulated AKT phosphorylation in 
the EDL muscle of LPHC rats.  
The proteasome is unable to degrade intact myofibrils [43], so upstream 
proteases are responsible for the release of myofibrillar proteins from the 
sarcomere for the subsequent ubiquitination and proteasomal degradation. 
Calpains [44] and caspase-3 [34, 45] are involved in the dissociation of 
myofibrils. According to our data, the activity of calpains was unchanged in the 
EDL muscles of LPHC rats, but a reduction in the caspase-3 activity was 
observed. Insulin has been also reported as an inhibitor of caspase-3 in skeletal 
muscles. Under muscle atrophy conditions, such as diabetes or chronic uremia, 
the accumulation of a 14 kDa actin fragment generated by the cleavage of 
actomyosin and cleaved by caspase-3 is observed [34]. When incubated in 
medium lacking metabolic substrates, L6 muscle cells showed an increase in 
actin cleavage; however, when insulin was added to the medium, the actin 
cleavage was blocked by a mechanism requiring PI3K [34]. Thus, it can be 
concluded that the decreased activity of caspase-3 in association with the 
decreased expression of atrogin-1 may be related the decreased availability of 
substrates for the proteasome in the EDL of LPHC rats. In the soleus muscle of 
LPHC rats, Batistela et al. [14] also observed similar changes in the proteolytic 
pathways and higher insulin sensitivity, with an increase in the IRβ content and 
in the insulin-stimulated Akt phosphorylation. However, in contrast to the 
findings in EDL muscle, the AMPK and p-AMPK content in the soleus muscle 
increased. Studies have shown that AMPK enhances the insulin sensitivity of 
some skeletal muscles [46, 47], and this effect has an important role in the 
inactivation of proteolysis and other catabolic pathways.  
As we previously noted, LPHC rats showed an increase in the circulating levels 
of corticosterone, TNF-α [16] and leptin [13] (Table S2; supplementary 
material), which have an inhibitory effect on protein synthesis. The results 
obtained in this present study suggested that these factors do not seem to have 
a significant effect on the reduced protein synthesis in the EDL muscle. The 
inhibitory action of TNF-α on protein synthesis occurs mainly via inhibition of the 
phosphorylation of IRS-1 at Ser307 [48], thus preventing the activation of other 
proteins downstream of insulin signaling, such as Akt. In this study, we did not 
find changes in the basal p-Akt content of the EDL muscles of LPHC rats, 
suggesting that despite the increase in the serum TNF-α level in LPHC rats, this 
cytokine did not inhibit the insulin signaling in the tissue. The inhibitory effect of 
glucocorticoids on protein synthesis occurs via activation of GSK-3β, a 
downstream target of insulin/Akt signaling that suppresses protein synthesis by 
inhibiting eukaryotic transcription factor 2B-dependent translation (eIF2B) [48]. 
In contrast, leptin decreases protein synthesis by impairing mTOR 
phosphorylation through activation of the AMPK pathway [50, 51]. In the present 
study, we did not observe changes in the GSK-3β and AMPK contents or in the 
phosphorylation levels of these proteins in the EDL muscles of LPHC rats. This 
fact suggests that the high levels of corticosterone and leptin in LPHC rats are 
not a determining factor in the reduction of the protein synthesis in EDL muscle.  
LPHC rats exhibited higher epinephrine and norepinephrine levels (Table S2; 
supplementary material) [15]. Numerous studies have shown that the 
administration of β2-agonists positively regulates skeletal muscle mass [52, 53]. 
The β2-adrenergic signaling pathway involves the activation of the Gαs protein, 
which in turn activates adenylate cyclase, resulting in increased cAMP 
production. Cyclic AMP-activated PKA initiates the transcription of many target 
genes via the phosphorylation of CREB at Ser133. In fact, CREB 
phosphorylation occurs rapidly in skeletal muscles in response to β2-adrenergic 
stimuli [52]. Furthermore, β2-adrenergic stimulation in skeletal muscle leads to 
the release of the Gβɣ subunit, which in turn activates PI3K/AKT/mTOR 
signaling and thus induces protein synthesis [52]. In the present study, a 48% 
reduction in the phosphorylation of CREB in the EDL muscles of LPHC rats was 
observed. In addition, the unaltered basal p-Akt levels suggest that β2-
adrenergic stimulation is not evoked in the EDL muscles of LPHC rats despite 
the increase in plasma catecholamine levels, suggesting that adrenergic 
signaling was not involved in the reduction of protein synthesis.  
Thus, our results suggest that despite the changes in the circulating levels of 
hormones and proinflammatory cytokines in LPHC rats, which strongly 
influenced the carbohydrate and lipid metabolism in the liver [54] and adipose 
tissues that were already reported in other studies [15, 16, 55], these factors are 
not the main determinants of protein metabolism in the EDL muscle.  
In summary, the following can be concluded: 
i) The increase in the insulin sensitivity of EDL muscles of the LPHC rats 
contributes to the reduced proteolysis through a reduction in the activity of 
caspase-3 and the ubiquitin-proteasome system. 
ii) The lower rate of protein synthesis in the EDL muscle of LPHC rats is 
probably linked to inhibition of the phosphorylation of mTOR as a consequence 
of the lower availability of specific amino acids, suggesting that the protein 
synthesis is directly affected by the quantity and quality of the amino acids from 
dietary protein.  
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TABLES. 
Table 1: Compositions (g/kg) of the control and low-protein, high-
carbohydrate diets. 
Ingredients Control diet LPHC diet 
Casein (84% protein) 202 71.5 
Cornstarch 397 480 
Dextrinized cornstarch 130.5 159 
Sucrose 100 121 
Soybean oil 70 70 
Fiber (cellulose) 50 50 
Mineral mix (AIN 93 G)* 35 35 
Vitamin mix (AIN 93 G)* 10 10 
L-cystine 3 1 
Choline bitartrate 2.5 2.5 
*For the detailed composition, see Reeves et al. (1993). 
 
 
 
 
 Table 2: The total food and protein intake, initial and final body weights, mass and 
protein content of the EDL muscle of low-protein, high-carbohydrate (LPHC) rats 
and of control rats after 15 days of treatment. 
       Parameter  Control LPHC  
Initial body weight (g) 93.57±1.14 93.08±1.41 
Final body weight (g) 191.52±2.95  148.05±6.88*  
Total food intake (g) 216.69± 6.32 244.96±9.57* 
Total protein intake (g) 36.83±1.02 14.70±0.61* 
EDL mass (g) 0.176± 0.012  0.113 ± 0.005** 
Muscle protein content (mg·g-1 muscle) 213.50±8.24  140.98±8.98** 
The data are the mean ± SEM of rats (n=8-10 rats). 
*P<0.05 vs. control rats; **P<0.01 vs. control rats (Student t-test). 
 
 
 
 
 
 
SUPPLEMENTARY MATERIAL 
Table S1: Weight and composition of the carcasses of low-protein, high-carbohydrate 
(LPHC) rats and control rats after 15 days of treatment. 
       Carcass parameter (g) Control LPHC 
Carcass weight 146.6±3.3 131.5±3.7* 
Water 94.6±2.4 77.4±1.9** 
Protein  31.0±1.0 23.4±0.4** 
Lipids  13.2±1.0 21.7±1.2** 
Ash  7.8± 0.2 9.0±0.4* 
The data are the mean ± SEM of rats (n=6 rats). *P < 0.05 vs. control rats, **P < 0.01 
vs. control rats (Student t-test). The data were previously published by Aparecida de 
França et al. [13]. 
 
 
 
 
 
 
 
 
 
 
Table S2: Hormone and catecholamine levels of low-protein, high-
carbohydrate (LPHC) rats and control rats after 15 days of treatment. 
       Hormones Control LPHC  
Fed rats   
Corticosterone (pg·mL-1) 147.5 ± 1.5 304.1 ± 1.9** 
Tumor necrosis factor-α (pg.mL-1) 54.3 ± 22.6 588.2 ± 69.6** 
Epinephrine (ng.mL-1) 3.9±0.6 5.4±0.4** 
Norepinephrine (ng.mL-1) 1.9±0.2 2.7±0.3** 
Leptin (ng.mL-1) 4.3±0.70 8.2±1.1** 
Insulin (ng.mL-1) 3.3±0.3 1.4±0.3* 
The data are the mean ± SEM of rats (n=4-12 rats).  
*P < 0.05 vs. control rats; **P < 0.01 vs. control rats (Student t-test).  
The data were previously published by Aparecida de França et al. [13], Buzelle 
et al. [15] and Dos Santos et al. [16]. 
 
 
 
 
 
 
 
Table S3: Post-feeding plasma amino acid levels of low-protein, high-carbohydrate (LPHC) 
rats and control rats after 15 days of treatment. 
Amino acid (µmol·L-1)  
Control 
 
LPHC 
 
% change †Essential 
Cysteine 36.29±1.81 23.46±2.65* −35 
Valine 110.95±4.92 66.67±5.25* −40 
Methionine 44.37±2.02 26.62±0.73* −40 
Isoleucine 52.22±2.68 31.12±1.76* −40  
Leucine 77.86±3.02 52.24±2.87* −33 
Tyrosine 39.08±1.87 20.69±1.87* −47 
Phenylalanine 27.08±1.41 22.32±1.51* −18 
Tryptophan 45.39±2.26 16.36±2.64* −64 
Histidine 39.42±2.61 41.53±2.37 NS 
Lysine 112.90±2.67 110.21±1.48 NS 
Non-essential    
Glutamic acid 47.83±1.255 62.68±4.643* +31 
Glycine 55.65±3.730 75.59±3.876* +36 
Alanine 137.94±3.449 171.27±3.675* +24 
Aspartic acid 12.35±2.895 13.33±1.228 NS 
Serine 158.05±1.646 157.47±2.211 NS 
Arginine 46.01±1.633 42.80±2.728 NS 
Note: Data are the mean ± SEM; *p < 0.05 compared with the control (Student's t test); NS= 
not significant. The data were previously published by Batistela et al. [14]. †Essential amino 
acid necessary for growing rats, recommended by Heger and Frydrych [56]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURES. 
 
Fig. 1: In vitro basal protein synthesis (A) and proteolysis (B) in the EDL muscle of 
control and low-protein, high-carbohydrate (LPHC) rats after 15 days of treatment. The 
data are presented as the mean ± SE (n=6-8 rats per group). * P<0.05 versus control 
diet (Student’s t test). 
 
Fig. 2: Protein content of cathepsins B (A) and L (B), cathepsin B activity (C) and 
protein content of autophagic components (D) in the EDL muscles of control and low-
protein, high-carbohydrate (LPHC) rats after 15 days of treatment. The data are 
presented as the mean ± SE (n=6-8 rats per group). *P<0.05 versus control diet 
(Student’s t test). 
 
Fig. 3: Activities of calpain (A) and caspase-3 (B) in the EDL muscles of control and 
low-protein, high-carbohydrate (LPHC) rats after 15 days of treatment. The data are 
presented as the mean ± SE (n=8-10 rats per group). *P<0.05 versus control diet 
(Student’s t test). 
 
 
Fig. 4: Protein content of atrogin-1 (A) and Ub conjugates (B) and chymotrypsin-like 
proteasome activity (C) in the EDL muscles of control and low-protein, high-
carbohydrate (LPHC) rats after 15 days of treatment. The data are presented as the 
mean ± SE (n=8-10 rats per group). *P<0.05 versus control diet (Student’s t test). 
 
 
Fig. 5: Protein content of IRβ (A) and AKT (B) and p-AKT/AKT ratio (C) in the EDL 
muscles of control and low-protein, high-carbohydrate (LPHC) rats after 15 days of 
treatment. The data are presented as the mean± SE (n=5-7 rats per group). *P<0.05 
versus control saline (Student’s t test). †P<0.05 versus LPHC saline (Student’s t test). 
 
 Fig. 6: Total content and phosphorylated/total ratio of 4E-BP1 (A), p70S6K (B), GSK-3β 
(C), AMPK (D) and CREB (E) in the EDL muscles of control and low-protein, high-
carbohydrate (LPHC) rats after 15 days of treatment. The data are presented as the 
mean ± SE (n=6 rats per group). *P<0.05 versus control (Student’s t test). †P<0.05 
versus control (Student’s t test). 
 
 
 
  
Fig. 7: Foxo1 content and p-Foxo1/Foxo1 ratio in the EDL muscles of control and low-
protein, high-carbohydrate (LPHC) rats after 15 days of treatment. The data are 
presented as the mean ± SE (n=6 rats per group). *P<0.05 versus control diet 
(Student’s t test). 
 
 
 
 
 
 
 
 
